Robert A. Ortenzio - 30 Jun 2026 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Reporting relationship: EXECUTIVE CHAIRMAN, Director, 10%+ Owner
Issuer ticker: SEM
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2026, 14:15:28 UTC
Prior SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ John F. Duggan, Attorney-in-Fact

Key filing fact

Robert A. Ortenzio filed Form 4 for SELECT MEDICAL HOLDINGS CORP (SEM) on 01 Jul 2026.

Key facts

This page summarizes Robert A. Ortenzio's Form 4 filing for SELECT MEDICAL HOLDINGS CORP (SEM).
6 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 01 Jul 2026, 14:15.

Change

Previous filing in this sequence was filed on 02 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000918697 Primary reporting owner

ORTENZIO ROBERT A

Relationship: EXECUTIVE CHAIRMAN, Director, 10%+ Owner
Address: C/O SELECT MEDICAL HOLDINGS CORPORATION, 4714 GETTYSBURG RD, MECHANICSBURG
Signature: /s/ John F. Duggan, Attorney-in-Fact
Signature date: 01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SEM transaction

Common Stock

Other

Transaction value
Shares: -7,081,788
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1, F2

SEM transaction

Common Stock

Other

Transaction value
Shares: -1,000,000
Change %: -78%
Price: $0.000000^*
Shares after: 279,000
Date: 30 Jun 2026
Ownership: By the Robert A. Ortenzio Descendants Trust
Footnotes: F1, F3, F4

SEM transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -279,000
Change %: -100%
Price: $16.50^*
Shares after: 0
Date: 30 Jun 2026
Ownership: By the Robert A. Ortenzio Descendants Trust
Footnotes: F1, F4, F5

SEM transaction

Common Stock

Other

Transaction value
Shares: -280,415
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 30 Jun 2026
Ownership: By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio
Footnotes: F1, F4, F6

SEM transaction

Common Stock

Other

Transaction value
Shares: -280,415
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 30 Jun 2026
Ownership: By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio
Footnotes: F1, F4, F7

SEM transaction

Common Stock

Other

Transaction value
Shares: -280,415
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 30 Jun 2026
Ownership: By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio
Footnotes: F1, F4, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Robert A. Ortenzio is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 8 footnotes

Footnote F1

This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026).

Footnote F2

Immediately prior to the effective time of the merger, the Reporting Person contributed 6,674,010 common shares and 407,778 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.

Footnote F3

Immediately prior to the effective time of the merger, The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares ("Rollover Shares") to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.

Footnote F4

The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Footnote F5

At the effective time of the merger, each of the shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest.

Footnote F6

Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.

Footnote F7

Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.

Footnote F8

Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.